EMA Authorised: Mysildecard (sildenafil) — Viatris Limited

View source ↗

Summary

The European Medicines Agency authorised Mysildecard (sildenafil) for indications related to hypertension and pulmonary hypertension, with Viatris Limited as th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension
• Systemic Arterial Hypertension

Drugs mentioned

• Mysildecard (sildenafil)

Snippet

Status: Authorised. Therapeutic area: Hypertension, Pulmonary. MAH: Viatris Limited. Decision date: 02/12/2025